1 Market Overview

1.1 Product Overview and Scope of Sexually Transmitted Disease (STD) Diagnosis

1.2 Classification of Sexually Transmitted Disease (STD) Diagnosis by Type

1.2.1 Overview: Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Type in 2021

1.2.3 Chlamydia testing

1.2.4 Syphilis testing

1.2.5 Gonorrhoea testing

1.2.6 Herpes simplex virus testing

1.2.7 Human papilloma virus testing

1.2.8 Human immunodeficiency virus testing

1.3 Global Sexually Transmitted Disease (STD) Diagnosis Market by Application

1.3.1 Overview: Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Government organizations

1.3.3 Hospitals

1.3.4 Diagnostic clinics

1.4 Global Sexually Transmitted Disease (STD) Diagnosis Market Size & Forecast

1.5 Global Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast by Region

1.5.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Region, (2017-2022)

1.5.3 North America Sexually Transmitted Disease (STD) Diagnosis Market Size and Prospect (2017-2028)

1.5.4 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size and Prospect (2017-2028)

1.5.6 South America Sexually Transmitted Disease (STD) Diagnosis Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Sexually Transmitted Disease (STD) Diagnosis Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Sexually Transmitted Disease (STD) Diagnosis Market Drivers

1.6.2 Sexually Transmitted Disease (STD) Diagnosis Market Restraints

1.6.3 Sexually Transmitted Disease (STD) Diagnosis Trends Analysis

2 Company Profiles

2.1 Abbott

2.1.1 Abbott Details

2.1.2 Abbott Major Business

2.1.3 Abbott Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

2.1.4 Abbott Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Abbott Recent Developments and Future Plans

2.2 Roche

2.2.1 Roche Details

2.2.2 Roche Major Business

2.2.3 Roche Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

2.2.4 Roche Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Roche Recent Developments and Future Plans

2.3 Thermo Fisher Scientific

2.3.1 Thermo Fisher Scientific Details

2.3.2 Thermo Fisher Scientific Major Business

2.3.3 Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

2.3.4 Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans

2.4 Aposcience

2.4.1 Aposcience Details

2.4.2 Aposcience Major Business

2.4.3 Aposcience Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

2.4.4 Aposcience Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Aposcience Recent Developments and Future Plans

2.5 BCR Diagnostics

2.5.1 BCR Diagnostics Details

2.5.2 BCR Diagnostics Major Business

2.5.3 BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

2.5.4 BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 BCR Diagnostics Recent Developments and Future Plans

2.6 BD Medical

2.6.1 BD Medical Details

2.6.2 BD Medical Major Business

2.6.3 BD Medical Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

2.6.4 BD Medical Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 BD Medical Recent Developments and Future Plans

2.7 Biocartis

2.7.1 Biocartis Details

2.7.2 Biocartis Major Business

2.7.3 Biocartis Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

2.7.4 Biocartis Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Biocartis Recent Developments and Future Plans

2.8 BioMerieux

2.8.1 BioMerieux Details

2.8.2 BioMerieux Major Business

2.8.3 BioMerieux Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

2.8.4 BioMerieux Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 BioMerieux Recent Developments and Future Plans

2.9 Bio-Rad

2.9.1 Bio-Rad Details

2.9.2 Bio-Rad Major Business

2.9.3 Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

2.9.4 Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Bio-Rad Recent Developments and Future Plans

2.10 Cepheid

2.10.1 Cepheid Details

2.10.2 Cepheid Major Business

2.10.3 Cepheid Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

2.10.4 Cepheid Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Cepheid Recent Developments and Future Plans

2.11 Danaher

2.11.1 Danaher Details

2.11.2 Danaher Major Business

2.11.3 Danaher Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

2.11.4 Danaher Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Danaher Recent Developments and Future Plans

2.12 DiaSorin

2.12.1 DiaSorin Details

2.12.2 DiaSorin Major Business

2.12.3 DiaSorin Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

2.12.4 DiaSorin Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 DiaSorin Recent Developments and Future Plans

2.13 Quidel

2.13.1 Quidel Details

2.13.2 Quidel Major Business

2.13.3 Quidel Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

2.13.4 Quidel Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Quidel Recent Developments and Future Plans

2.14 GenMark Diagnostics

2.14.1 GenMark Diagnostics Details

2.14.2 GenMark Diagnostics Major Business

2.14.3 GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

2.14.4 GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 GenMark Diagnostics Recent Developments and Future Plans

2.15 Hologic

2.15.1 Hologic Details

2.15.2 Hologic Major Business

2.15.3 Hologic Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

2.15.4 Hologic Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Hologic Recent Developments and Future Plans

2.16 OraSure Technologies

2.16.1 OraSure Technologies Details

2.16.2 OraSure Technologies Major Business

2.16.3 OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

2.16.4 OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 OraSure Technologies Recent Developments and Future Plans

2.17 Qualigen

2.17.1 Qualigen Details

2.17.2 Qualigen Major Business

2.17.3 Qualigen Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

2.17.4 Qualigen Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Qualigen Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Sexually Transmitted Disease (STD) Diagnosis Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Sexually Transmitted Disease (STD) Diagnosis Players Market Share in 2021

3.2.2 Top 10 Sexually Transmitted Disease (STD) Diagnosis Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Sexually Transmitted Disease (STD) Diagnosis Players Head Office, Products and Services Provided

3.4 Sexually Transmitted Disease (STD) Diagnosis Mergers & Acquisitions

3.5 Sexually Transmitted Disease (STD) Diagnosis New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Sexually Transmitted Disease (STD) Diagnosis Revenue and Market Share by Type (2017-2022)

4.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Application (2017-2022)

5.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Sexually Transmitted Disease (STD) Diagnosis Revenue by Type (2017-2028)

6.2 North America Sexually Transmitted Disease (STD) Diagnosis Revenue by Application (2017-2028)

6.3 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country

6.3.1 North America Sexually Transmitted Disease (STD) Diagnosis Revenue by Country (2017-2028)

6.3.2 United States Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2017-2028)

6.3.3 Canada Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2017-2028)

6.3.4 Mexico Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Sexually Transmitted Disease (STD) Diagnosis Revenue by Type (2017-2028)

7.2 Europe Sexually Transmitted Disease (STD) Diagnosis Revenue by Application (2017-2028)

7.3 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country

7.3.1 Europe Sexually Transmitted Disease (STD) Diagnosis Revenue by Country (2017-2028)

7.3.2 Germany Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2017-2028)

7.3.3 France Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2017-2028)

7.3.5 Russia Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2017-2028)

7.3.6 Italy Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue by Type (2017-2028)

8.2 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue by Application (2017-2028)

8.3 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Region

8.3.1 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue by Region (2017-2028)

8.3.2 China Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2017-2028)

8.3.3 Japan Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2017-2028)

8.3.4 South Korea Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2017-2028)

8.3.5 India Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2017-2028)

8.3.7 Australia Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Sexually Transmitted Disease (STD) Diagnosis Revenue by Type (2017-2028)

9.2 South America Sexually Transmitted Disease (STD) Diagnosis Revenue by Application (2017-2028)

9.3 South America Sexually Transmitted Disease (STD) Diagnosis Market Size by Country

9.3.1 South America Sexually Transmitted Disease (STD) Diagnosis Revenue by Country (2017-2028)

9.3.2 Brazil Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2017-2028)

9.3.3 Argentina Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue by Type (2017-2028)

10.2 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue by Application (2017-2028)

10.3 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Country

10.3.1 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue by Country (2017-2028)

10.3.2 Turkey Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2017-2028)

10.3.4 UAE Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Sexually Transmitted Disease (STD) Diagnosis Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Sexually Transmitted Disease (STD) Diagnosis Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Sexually Transmitted Disease (STD) Diagnosis Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Region (2017-2022)

Table 5. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Region (2023-2028)

Table 6. Abbott Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Major Business

Table 8. Abbott Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

Table 9. Abbott Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Roche Corporate Information, Head Office, and Major Competitors

Table 11. Roche Major Business

Table 12. Roche Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

Table 13. Roche Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors

Table 15. Thermo Fisher Scientific Major Business

Table 16. Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

Table 17. Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Aposcience Corporate Information, Head Office, and Major Competitors

Table 19. Aposcience Major Business

Table 20. Aposcience Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

Table 21. Aposcience Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. BCR Diagnostics Corporate Information, Head Office, and Major Competitors

Table 23. BCR Diagnostics Major Business

Table 24. BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

Table 25. BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. BD Medical Corporate Information, Head Office, and Major Competitors

Table 27. BD Medical Major Business

Table 28. BD Medical Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

Table 29. BD Medical Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Biocartis Corporate Information, Head Office, and Major Competitors

Table 31. Biocartis Major Business

Table 32. Biocartis Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

Table 33. Biocartis Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. BioMerieux Corporate Information, Head Office, and Major Competitors

Table 35. BioMerieux Major Business

Table 36. BioMerieux Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

Table 37. BioMerieux Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Bio-Rad Corporate Information, Head Office, and Major Competitors

Table 39. Bio-Rad Major Business

Table 40. Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

Table 41. Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Cepheid Corporate Information, Head Office, and Major Competitors

Table 43. Cepheid Major Business

Table 44. Cepheid Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

Table 45. Cepheid Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Danaher Corporate Information, Head Office, and Major Competitors

Table 47. Danaher Major Business

Table 48. Danaher Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

Table 49. Danaher Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. DiaSorin Corporate Information, Head Office, and Major Competitors

Table 51. DiaSorin Major Business

Table 52. DiaSorin Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

Table 53. DiaSorin Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Quidel Corporate Information, Head Office, and Major Competitors

Table 55. Quidel Major Business

Table 56. Quidel Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

Table 57. Quidel Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. GenMark Diagnostics Corporate Information, Head Office, and Major Competitors

Table 59. GenMark Diagnostics Major Business

Table 60. GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

Table 61. GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Hologic Corporate Information, Head Office, and Major Competitors

Table 63. Hologic Major Business

Table 64. Hologic Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

Table 65. Hologic Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. OraSure Technologies Corporate Information, Head Office, and Major Competitors

Table 67. OraSure Technologies Major Business

Table 68. OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

Table 69. OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Qualigen Corporate Information, Head Office, and Major Competitors

Table 71. Qualigen Major Business

Table 72. Qualigen Sexually Transmitted Disease (STD) Diagnosis Product and Solutions

Table 73. Qualigen Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Global Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 75. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 76. Breakdown of Sexually Transmitted Disease (STD) Diagnosis by Company Type (Tier 1, Tier 2 and Tier 3)

Table 77. Sexually Transmitted Disease (STD) Diagnosis Players Head Office, Products and Services Provided

Table 78. Sexually Transmitted Disease (STD) Diagnosis Mergers & Acquisitions in the Past Five Years

Table 79. Sexually Transmitted Disease (STD) Diagnosis New Entrants and Expansion Plans

Table 80. Global Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Type (2017-2022)

Table 81. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Type (2017-2022)

Table 82. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Forecast by Type (2023-2028)

Table 83. Global Sexually Transmitted Disease (STD) Diagnosis Revenue by Application (2017-2022)

Table 84. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Forecast by Application (2023-2028)

Table 85. North America Sexually Transmitted Disease (STD) Diagnosis Revenue by Type (2017-2022) & (USD Million)

Table 86. North America Sexually Transmitted Disease (STD) Diagnosis Revenue by Type (2023-2028) & (USD Million)

Table 87. North America Sexually Transmitted Disease (STD) Diagnosis Revenue by Application (2017-2022) & (USD Million)

Table 88. North America Sexually Transmitted Disease (STD) Diagnosis Revenue by Application (2023-2028) & (USD Million)

Table 89. North America Sexually Transmitted Disease (STD) Diagnosis Revenue by Country (2017-2022) & (USD Million)

Table 90. North America Sexually Transmitted Disease (STD) Diagnosis Revenue by Country (2023-2028) & (USD Million)

Table 91. Europe Sexually Transmitted Disease (STD) Diagnosis Revenue by Type (2017-2022) & (USD Million)

Table 92. Europe Sexually Transmitted Disease (STD) Diagnosis Revenue by Type (2023-2028) & (USD Million)

Table 93. Europe Sexually Transmitted Disease (STD) Diagnosis Revenue by Application (2017-2022) & (USD Million)

Table 94. Europe Sexually Transmitted Disease (STD) Diagnosis Revenue by Application (2023-2028) & (USD Million)

Table 95. Europe Sexually Transmitted Disease (STD) Diagnosis Revenue by Country (2017-2022) & (USD Million)

Table 96. Europe Sexually Transmitted Disease (STD) Diagnosis Revenue by Country (2023-2028) & (USD Million)

Table 97. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue by Type (2017-2022) & (USD Million)

Table 98. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue by Type (2023-2028) & (USD Million)

Table 99. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue by Application (2017-2022) & (USD Million)

Table 100. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue by Application (2023-2028) & (USD Million)

Table 101. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue by Region (2017-2022) & (USD Million)

Table 102. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue by Region (2023-2028) & (USD Million)

Table 103. South America Sexually Transmitted Disease (STD) Diagnosis Revenue by Type (2017-2022) & (USD Million)

Table 104. South America Sexually Transmitted Disease (STD) Diagnosis Revenue by Type (2023-2028) & (USD Million)

Table 105. South America Sexually Transmitted Disease (STD) Diagnosis Revenue by Application (2017-2022) & (USD Million)

Table 106. South America Sexually Transmitted Disease (STD) Diagnosis Revenue by Application (2023-2028) & (USD Million)

Table 107. South America Sexually Transmitted Disease (STD) Diagnosis Revenue by Country (2017-2022) & (USD Million)

Table 108. South America Sexually Transmitted Disease (STD) Diagnosis Revenue by Country (2023-2028) & (USD Million)

Table 109. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue by Type (2017-2022) & (USD Million)

Table 110. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue by Type (2023-2028) & (USD Million)

Table 111. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue by Application (2017-2022) & (USD Million)

Table 112. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue by Application (2023-2028) & (USD Million)

Table 113. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue by Country (2017-2022) & (USD Million)

Table 114. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Sexually Transmitted Disease (STD) Diagnosis Picture

Figure 2. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Type in 2021

Figure 3. Chlamydia testing

Figure 4. Syphilis testing

Figure 5. Gonorrhoea testing

Figure 6. Herpes simplex virus testing

Figure 7. Human papilloma virus testing

Figure 8. Human immunodeficiency virus testing

Figure 9. Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Application in 2021

Figure 10. Government organizations Picture

Figure 11. Hospitals Picture

Figure 12. Diagnostic clinics Picture

Figure 13. Global Sexually Transmitted Disease (STD) Diagnosis Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 14. Global Sexually Transmitted Disease (STD) Diagnosis Revenue and Forecast (2017-2028) & (USD Million)

Figure 15. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Region (2017-2028)

Figure 16. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Region in 2021

Figure 17. North America Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Europe Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. South America Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Middle East and Africa Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. Sexually Transmitted Disease (STD) Diagnosis Market Drivers

Figure 23. Sexually Transmitted Disease (STD) Diagnosis Market Restraints

Figure 24. Sexually Transmitted Disease (STD) Diagnosis Market Trends

Figure 25. Abbott Recent Developments and Future Plans

Figure 26. Roche Recent Developments and Future Plans

Figure 27. Thermo Fisher Scientific Recent Developments and Future Plans

Figure 28. Aposcience Recent Developments and Future Plans

Figure 29. BCR Diagnostics Recent Developments and Future Plans

Figure 30. BD Medical Recent Developments and Future Plans

Figure 31. Biocartis Recent Developments and Future Plans

Figure 32. BioMerieux Recent Developments and Future Plans

Figure 33. Bio-Rad Recent Developments and Future Plans

Figure 34. Cepheid Recent Developments and Future Plans

Figure 35. Danaher Recent Developments and Future Plans

Figure 36. DiaSorin Recent Developments and Future Plans

Figure 37. Quidel Recent Developments and Future Plans

Figure 38. GenMark Diagnostics Recent Developments and Future Plans

Figure 39. Hologic Recent Developments and Future Plans

Figure 40. OraSure Technologies Recent Developments and Future Plans

Figure 41. Qualigen Recent Developments and Future Plans

Figure 42. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Players in 2021

Figure 43. Sexually Transmitted Disease (STD) Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 44. Global Top 3 Players Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share in 2021

Figure 45. Global Top 10 Players Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share in 2021

Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 47. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Type in 2021

Figure 48. Global Sexually Transmitted Disease (STD) Diagnosis Market Share Forecast by Type (2023-2028)

Figure 49. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Application in 2021

Figure 50. Global Sexually Transmitted Disease (STD) Diagnosis Market Share Forecast by Application (2023-2028)

Figure 51. North America Sexually Transmitted Disease (STD) Diagnosis Sales Market Share by Type (2017-2028)

Figure 52. North America Sexually Transmitted Disease (STD) Diagnosis Sales Market Share by Application (2017-2028)

Figure 53. North America Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Country (2017-2028)

Figure 54. United States Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Canada Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Mexico Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Europe Sexually Transmitted Disease (STD) Diagnosis Sales Market Share by Type (2017-2028)

Figure 58. Europe Sexually Transmitted Disease (STD) Diagnosis Sales Market Share by Application (2017-2028)

Figure 59. Europe Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Country (2017-2028)

Figure 60. Germany Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. France Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. United Kingdom Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Russia Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Italy Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Sales Market Share by Type (2017-2028)

Figure 66. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Sales Market Share by Application (2017-2028)

Figure 67. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Region (2017-2028)

Figure 68. China Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Japan Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. South Korea Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. India Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Australia Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. South America Sexually Transmitted Disease (STD) Diagnosis Sales Market Share by Type (2017-2028)

Figure 75. South America Sexually Transmitted Disease (STD) Diagnosis Sales Market Share by Application (2017-2028)

Figure 76. South America Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Country (2017-2028)

Figure 77. Brazil Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Argentina Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Middle East and Africa Sexually Transmitted Disease (STD) Diagnosis Sales Market Share by Type (2017-2028)

Figure 80. Middle East and Africa Sexually Transmitted Disease (STD) Diagnosis Sales Market Share by Application (2017-2028)

Figure 81. Middle East and Africa Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Country (2017-2028)

Figure 82. Turkey Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 83. Saudi Arabia Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 84. UAE Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 85. Methodology

Figure 86. Research Process and Data Source